Skip to content

Feasibility of a day clinic for integrative prehabilitation complementary to neoadjuvant tumor treatment in an open group setting

Feasibility of a day clinic for integrative prehabilitation complementary to neoadjuvant tumor treatment in an open group setting

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00032892
Enrollment
20
Registered
2023-10-19
Start date
2023-07-03
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C15-C26 C67 C61 C50 C54 C56 C53

Interventions

Group 1: The day-clinic once weekly multimodal prehabilitation group program consists of: 1.) Naturopathic counselling 2.) Physical exercise program 3.) nutritional optimization 4.) External naturo

Sponsors

Universitätsklinikum Ulm
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with abdominal cancer (including stomach cancer and extraperitoneal cancers like pancreatic, bladder, rectal, esophageal, endometrial, ovarial and cervical cancer) or breast cancer 2. Patients planned to undergo or currently undergoing neoadjuvant treatment 3. Written informed consent 4. Ability to understand character and individual consequences of the clinical trial

Exclusion criteria

Exclusion criteria: 1. Participation in another interventional trial with interference on intervention and outcome of this trial 2. American Society of Anesthesiologists (ASA) grade >3 3. Immobility or inability to walk unaided 4. Expected lack of compliance

Design outcomes

Primary

MeasureTime frame
1.Recruitment of a minimum of 8 patients within 3 months. 2.Adherence to the day clinic defined as the ratio of missed appointments during the participation in the program

Secondary

MeasureTime frame
3. EORTC QLQ-C30 4. A core set of 13 cancer-associated symptoms (fatigue, insomnia, pain, shortness of breath, cognitive problems, anxiety, loss of appetite, nausea, vomiting, depression, neuropathy, constipation, diarrhea) at baseline and once weekly during pre-habilitation with the Patient-Reported Out-comes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) 5. Quality of recovery according to QoR-15 at baseline and on POD 4 (or at discharge whatever comes first). 6. The Patient Health Questionnaire depression scale (PHQ-4) 7. Sleep Quality (PSQI) 8. Mindfulness (Five-Facet Mindfulness Questionnaire FFMQ-D) 9. Patients’ satisfaction regarding the Day Clinic Program assessed with a non-validated questionnaire 10. Fatigue (NRS) 11. Qualitative interview Clinician-reported outcome measures 12. Postoperative complications =3 according to Dindo-Clavien 13. Duration of postoperative hospital stay 14. Readmission after initial discharge 15. 6-minute walking test at baseline, end of day clinic 16. Hand grip strength using a dynamometer 17. 1-minute sit to stand test 18. Intensity of analgesic treatment according to the WHO analgesic step ladder 19. BMI at baseline, end of day clinic and on POD 30. 20. Adherence to neoadjuvant treatment during PRIME-DC program

Countries

Germany

Contacts

Public ContactChristian Raff

Universitätsklinikum Ulm Klinik für Allgemein- und Viszeralchirurgie

christian.raff@uniklinik-ulm.de+4973150053538

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026